Table I.
Inhibitors used in the present study.
| Name | Effect | Supplier | Cat. no. | Dose |
|---|---|---|---|---|
| Vorinostat (SAHA) | HDAC inhibitor | Focus Biomolecules | 10-1067 | 1 µM |
| TSA | HDAC inhibitor | Wako Pure Chemical Industries | 203-17561 | 100 nM |
| Chaetocin | Suv39 histone methyltransferase inhibitor | Abcam | ab144534 | 50 nM |
| Bix-01294 | G9a histone methyltransferease inhibitor | Cayman Chemical Company | 13124 | 5 µM |
| 5-Aza-cytidine | DNA methyltransferase inhibitor | TCI Chemicals | A2033 | 1 µM |
| Zebularine | DNA methyltransferase inhibitor | Tocris Bioscience | 2293 | 10 µM |
| NU9056 | HAT inhibitor KAT5, p300, pCAF and GCN5 | Tocris Bioscience | 4903 | 5 µM |
SAHA, suberoylanilide hydroxamic acid; TSA, trichostatin A.